Nosova Emily V, Chong Karen C, Alley Hugh F, Harris William S, Boscardin W John, Conte Michael S, Owens Christopher D, Grenon S Marlene
Department of Surgery, University of California, San Francisco, San Francisco, Calif; VIPERx Laboratory, San Francisco, Calif.
Department of Medicine, Sanford School of Medicine, University of South Dakota, Sioux Falls, SDak; Health Diagnostic Laboratory, Inc, Richmond, Va.
J Vasc Surg. 2014 Nov;60(5):1325-1331. doi: 10.1016/j.jvs.2014.05.040. Epub 2014 Jun 20.
Despite available medical therapies, patients with peripheral arterial disease (PAD) remain at high risk for cardiovascular events. The n-3 polyunsaturated fatty acids (PUFA), derived from marine sources, have been shown to improve cardiovascular mortality. The Omega-3 Index (O3I), a proportion of the n-3 PUFA eicosapentaenoic acid and docosahexaenoic acid in the red blood cell membrane, correlates with cardiovascular risk. Previous investigations have found that n-3 PUFA supplementation, fish consumption, older age, and smoking history affect the O3I in different patient populations, although similar correlations have never been explored in PAD. We hypothesized that in our PAD cohort, blood content of omega-3 fatty acids would directly and positively correlate with a history of fish oil supplementation and older age and inversely correlate with a smoking history and obesity.
This cross-sectional study included 111 patients who had an ankle-brachial index of <0.9 associated with claudication symptoms. We used linear regression to determine the association between clinical factors and the O3I.
The mean age of the cohort was 69 ± 8 years; 37% had diabetes mellitus (hemoglobin A1c, 7% ± 1%), and 94% reported current smoking or a history of smoking. The mean O3I was 5% ± 2%. In multivariate linear regression analysis, the O3I was associated with older age, increasing body mass index, and a history of smoking and fish oil intake.
This is the first report of the relation between blood content of omega-3 fatty acids and clinical factors in a PAD population. In patients with PAD, older age, elevated body mass index, and prior fish oil supplementation predicted a higher O3I. A history of smoking correlated with a lower O3I. These results demonstrate that the O3I is a reliable measure of dietary n-3 PUFA intake and that clinical factors related to the O3I in PAD are similar to those observed in other populations.
尽管有可用的药物治疗,但外周动脉疾病(PAD)患者仍面临心血管事件的高风险。源自海洋的n-3多不饱和脂肪酸(PUFA)已被证明可降低心血管疾病死亡率。红细胞膜中n-3多不饱和脂肪酸二十碳五烯酸和二十二碳六烯酸的比例——欧米伽-3指数(O3I)与心血管风险相关。先前的研究发现,补充n-3多不饱和脂肪酸、食用鱼类、年龄较大和吸烟史会影响不同患者群体的O3I,尽管在PAD患者中从未探讨过类似的相关性。我们假设,在我们的PAD队列中,欧米伽-3脂肪酸的血液含量将与鱼油补充史和年龄呈直接正相关,与吸烟史和肥胖呈负相关。
这项横断面研究纳入了111例踝臂指数<0.9且伴有间歇性跛行症状的患者。我们使用线性回归来确定临床因素与O3I之间的关联。
该队列的平均年龄为69±8岁;37%患有糖尿病(糖化血红蛋白,7%±1%),94%报告目前吸烟或有吸烟史。平均O3I为5%±2%。在多变量线性回归分析中,O3I与年龄较大、体重指数增加、吸烟史和鱼油摄入量相关。
这是关于PAD人群中欧米伽-3脂肪酸血液含量与临床因素之间关系的首份报告。在PAD患者中,年龄较大、体重指数升高和既往补充鱼油可预测较高的O3I。吸烟史与较低的O3I相关。这些结果表明,O3I是膳食n-3多不饱和脂肪酸摄入量的可靠指标,且PAD中与O3I相关的临床因素与其他人群中观察到的相似。